SC 13G: Apellis Pharmaceuticals, Inc.

AI Summary

SC 13G filing by Apellis Pharmaceuticals, Inc..

Risk Assessment

Risk Level: low

Key Financial Figures

• $0.0001 — Inc. (Name of Issuer) Common Stock, $0.0001 par value per share (Title of Class o

Filing Documents

• deeptrack-apls111524.htm (SC 13G) — 99KB
• 0001172661-24-005353.txt ( ) — 101KB

(a)Name of Issuer

Item 1. (a)Name of Issuer Apellis Pharmaceuticals Inc.

(b)Address of Issuer’s Principal

Item 1. (b)Address of Issuer’s Principal Executive Offices 100 Fifth Avenue Waltham, MA 02451

(a)Names of Persons Filing

Item 2. (a)Names of Persons Filing: (i) Deep Track Capital, LP (ii) Deep Track Biotechnology Master Fund, Ltd. (iii) David Kroin

( b)Address

Item 2. ( b)Address of Principal Business Office: (i) 200 Greenwich Ave, 3rd Floor, Greenwich, CT 06830 (ii) c/o Walkers Corporate Limited, 190 Elgin Ave, George Town, KY1-9001, Cayman Islands (iii) c/o Deep Track Capital, LP, 200 Greenwich Ave, 3rd Floor, Greenwich, CT 06830

(c) Citizenship

Item 2. (c) Citizenship: (i) Delaware (ii) Cayman Islands (iii) United States

(d)Title of Class of Securities

Item 2. (d)Title of Class of Securities Common Stock, $0.0001 par value per share (the “Common Stock”)

(e) CUSIP No

Item 2. (e) CUSIP No.: 03753U106 CUSIP No. 03753U106 SCHEDULE 13G Page 6 of 9 Pages

If

Item 3.If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a: (a) Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o); (b) Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c); (c) Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c); (d) Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8); (e) o An investment adviser in accordance with 240.13d-1(b)(1)(ii)(E); (f) An employee benefit plan or endowment fund in accordance with 240.13d-1(b)(1)(ii)(F); (g) A parent holding company or control person in accordance with 240.13d-1(b)(1)(ii)(G); (h) A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); (i) A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3); (j) A non-U.S. institution in accordance with 240.13d-1(b)(1)(ii)(J); (k) A group, in accordance with 240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with 240.13d-1(b)(1)(ii)(J), please specify the type of institution: CUSIP No. 03753U106 SCHEDULE 13G Page 7 of 9 Pages Item 4.Ownership Information with respect to the Reporting Persons' ownership of the Common Stock as of November 15, 2024, is incorporated by reference to items (5) - (9) and (11) of the cover page of the respective Reporting Person. The amount beneficially owned by each Reporting Person is determined based on 124,393,017 Common Stock outstanding as of October 29, 2024, according to the issuer’s Form 10-Q filed with the SEC on November 5, 2024. Item 5.Ownership of Five Percent or Less of a Class If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial

View Full Filing

View this SC 13G filing on SEC EDGAR